PMID: 18212097DOI: 10.1128/aac.01485-07Jan 24, 2008Paper
Induction of L1 and L2 beta-lactamase production in Stenotrophomonas maltophilia is dependent on an AmpR-type regulator.
Antimicrobial Agents and Chemotherapy
Aki Okazaki, Matthew B Avison
Abstract
A divergently oriented ampR has been located upstream of blaL2 in Stenotrophomonas maltophilia. AmpR is necessary for L1 and L2 beta-lactamase induction in response to beta-lactam challenge, and activation of AmpR is sufficient to induce L1 and L2 production. L1 induction requires more activation of AmpR than does L2 induction.
References
Oct 1, 1991·Journal of Medical Microbiology·M AkovaD M Livermore
Oct 5, 1990·Journal of Molecular Biology·S F AltschulD J Lipman
Feb 11, 1998·Clinical Microbiology Reviews·M Denton, K G Kerr
Jul 14, 1998·Gene·T T HoangH P Schweizer
Feb 19, 2000·Antimicrobial Agents and Chemotherapy·A KugaM Inoue
Nov 4, 2000·The Journal of Antimicrobial Chemotherapy·M B AvisonP M Bennett
Dec 5, 2000·The Journal of Antimicrobial Chemotherapy·M B AvisonT R Walsh
Feb 13, 2001·Antimicrobial Agents and Chemotherapy·M B AvisonT R Walsh
Jun 23, 2001·The Journal of Antimicrobial Chemotherapy·J M Andrews
Jan 30, 2002·The Journal of Antimicrobial Chemotherapy·Matthew B AvisonPeter M Bennett
Oct 18, 2002·Antimicrobial Agents and Chemotherapy·Niels BaggeNiels Høiby
May 15, 2003·The Journal of Antimicrobial Chemotherapy·Pannika NiumsupMatthew B Avison
Dec 25, 2003·Antimicrobial Agents and Chemotherapy·Shu-Fen WengYi-Hsiung Tseng
Jul 16, 2004·The Journal of Antimicrobial Chemotherapy·Virginia C GouldMatthew B Avison
Dec 15, 2005·The Journal of Antimicrobial Chemotherapy·Virginia C GouldMatthew B Avison
Apr 7, 2006·The Journal of Antimicrobial Chemotherapy·Virginia C Gould, Matthew B Avison
Apr 28, 2006·Antimicrobial Agents and Chemotherapy·Carlos JuanAntonio Oliver
Nov 8, 2006·Antimicrobial Agents and Chemotherapy·Aki Okazaki, Matthew B Avison
❮ Previous
Next ❯
Citations
Apr 17, 2010·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Y-C ChangT-C Chung
Jun 19, 2012·Journal of Proteome Research·Wei LiuJing Yuan
Jul 2, 2011·The Journal of Antimicrobial Chemotherapy·Cheng-Wen LinTsuey-Ching Yang
Nov 14, 2012·Antimicrobial Agents and Chemotherapy·Virginia C GouldMatthew B Avison
Apr 14, 2010·Antimicrobial Agents and Chemotherapy·Yi-Wei HuangTsuey-Ching Yang
May 6, 2009·Antimicrobial Agents and Chemotherapy·Tsuey-Ching YangYu-Tzu Lin
Jan 19, 2012·Antimicrobial Agents and Chemotherapy·Yi-Wei HuangTsuey-Ching Yang
Feb 1, 2012·Antimicrobial Agents and Chemotherapy·Lisandro J González, Alejandro J Vila
Jan 11, 2012·Clinical Microbiology Reviews·Joanna S Brooke
Nov 13, 2012·Journal of Bacteriology·Shiping SongYan Li
Apr 6, 2012·PloS One·Deepak BalasubramanianKalai Mathee
Jul 9, 2011·PLoS Pathogens·Alvaro HernándezJosé L Martínez
Aug 8, 2009·Future Microbiology·Maria B SanchezJose L Martinez
Feb 19, 2014·Annals of Hematology·Minako MoriTakayuki Takahashi
Jun 5, 2012·Applied Microbiology and Biotechnology·Laurence Van OudenhoveBart Devreese
Apr 21, 2011·Expert Review of Anti-infective Therapy·Iain J AbbottLeon J Worth
Sep 17, 2011·Research in Microbiology·Tsuey-Ching YangRouh-Mei Hu
Dec 24, 2015·Frontiers in Microbiology·Ebrahim M AbdaWolfgang R Streit
Apr 28, 2009·The Lancet Infectious Diseases·W John LooneyKathrin Mühlemann
Dec 17, 2008·Research in Microbiology·Cheng-Wen LinTsuey-Ching Yang
Jan 22, 2013·Reproduction in Domestic Animals = Zuchthygiene·C KilburnR D Murray
Sep 22, 2015·Frontiers in Microbiology·Ya-Ting ChangPo-Ren Hsueh
Dec 25, 2012·Journal of Medical Microbiology·Koichi Tanimoto
May 1, 2010·Microbiology·Amy E TaylerMatthew B Avison
Jul 30, 2014·Pathogens and Disease·Deepak BalasubramanianKalai Mathee
Nov 1, 2016·Environmental Science & Technology·Fang WangWoo Jun Sul
Dec 1, 2017·Antibiotics·Etienne RuppéJacques Schrenzel
Oct 14, 2017·FEMS Microbiology Reviews·Carlos JuanAntonio Oliver
May 31, 2018·Antimicrobial Agents and Chemotherapy·Karina Calvopiña, Matthew B Avison
Aug 28, 2013·Antimicrobial Agents and Chemotherapy·Asmaa TalfanMatthew B Avison
May 4, 2016·Antimicrobial Agents and Chemotherapy·Karina CalvopiñaMatthew B Avison
Aug 20, 2014·Antimicrobial Agents and Chemotherapy·Jianhua YinHaichun Gao
Aug 16, 2017·MSphere·Ryuichi NakanoRyoichi Okamoto
Aug 5, 2017·Journal of Medical Microbiology·Akira FukudaYutaka Tamura
Sep 7, 2017·Molecular Microbiology·Karina CalvopiñaMatthew B Avison
Feb 14, 2020·Expert Review of Anti-infective Therapy·Teresa Gil-GilPaula Blanco
Nov 28, 2019·Molecular Microbiology·Karina CalvopiñaMatthew B Avison
Jan 17, 2009·Letters in Applied Microbiology·R-M HuT-C Yang
Jul 20, 2017·The Journal of Microbiology·So Yeon KimKwan Soo Ko
Jul 4, 2019·MBio·Maria F MojicaRobert A Bonomo
May 29, 2020·Open Forum Infectious Diseases·Bin CaiRoger Echols
Aug 29, 2018·Antimicrobial Agents and Chemotherapy·Hsin-Hui HuangTsuey-Ching Yang
Mar 21, 2020·Microbiology Resource Announcements·Shiori YamamotoHiroshi Asakura
Dec 24, 2018·Frontiers in Microbiology·Fabio GentiliniRenato Giulio Zanoni
Aug 28, 2020·Frontiers in Cellular and Infection Microbiology·Zhongliang DuanChunmei Ying
May 3, 2019·FEMS Microbiology Letters·Eliana AlcarazBeatriz Passerini de Rossi
Jun 30, 2019·Microbiome·Nachiket P MaratheD G Joakim Larsson
Mar 22, 2019·Scientific Reports·Paula BlancoJosé Luis Martínez
Oct 1, 2020·BMC Microbiology·Zhongliang DuanChunmei Ying
Jul 17, 2020·Frontiers in Microbiology·Danielle L PetersJonathan J Dennis
❮ Previous
Next ❯
Related Concepts
Related Feeds
CRISPR Screens in Drug Resistance
CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.
Related Papers
The Journal of Antimicrobial Chemotherapy
Matthew B AvisonP M Bennett
Antimicrobial Agents and Chemotherapy
Rouh-Mei HuTsuey-Ching Yang
Antimicrobial Agents and Chemotherapy
Aki Okazaki, Matthew B Avison
Letters in Applied Microbiology
R-M HuT-C Yang